El Vínculo El Vínculo.
Awarded European Union Services

Oncotype Dx Gene Expression Profiling Test

Buyer: Health Service Executive (HSE)

Published
31 October 2024
Place of performance
IE061
Lots
1
Notice number
00662725-2024
Reference
d5a45ace-c524-4a3f-8c21-3cc5b3d1c56d
Official source
Official source

CPV codes

Description

Gene Expression Profiling (GEP) tests are intended to provide information on disease prognosis and some may also be able to identify the patients who are most likely to benefit from chemotherapy. In this way they support clinical decision-making regarding a patient’s need for adjuvant chemotherapy. This test is used to inform decision-making in relation to the management of early-stage invasive breast cancer. The Oncotype Dx has been contracted for use in Ireland since 2011.

Award criteria

Official publications

Other tenders from Health Service Executive (HSE)

See all →

Frequently asked questions

Who is the buyer of this tender?
The contracting authority is Health Service Executive (HSE) (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.